journal article·2026-05Open access

IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome

Baoying Liao, Chuyu Yun, Hongying Shan, Yuqian Wang, Xiunan Chen, Weisi Lian, Tianliu Peng, Min Zhao, Xunsi Qin, Kailun Hu, Ping Zhou, Yue Wang, Yanli Pang, Rong Li

Advanced Science· Volume 13· Issue 27

Abstract

ABSTRACT Polycystic ovary syndrome (PCOS) is a metabolic disorder and a major cause of infertility, affecting approximately 5–18% of women of reproductive age worldwide. Emerging evidence suggests that intrinsic endometrial defects play a critical role in PCOS‐associated infertility; however, the underlying molecular mechanisms remain poorly understood. In this study, we demonstrated that interleukin 22 (IL‐22) signaling directly modulated endometrial function and that downregulation of the IL‐22‐STAT3 pathway contributed to impaired endometrial receptivity in PCOS. Consistently, exogenous IL‐22 administration in a PCOS‐like mouse model restored STAT3 phosphorylation and effectively alleviated implantation failure by enhancing endometrial receptivity. Mechanistically, we identified insulin‐like growth factor‐binding protein 5 (IGFBP5) as a direct downstream target of STAT3 in endometrial organoids derived from patients with PCOS. Knockdown of IGFBP5 in the uteri of PCOS‐like mice abolished the beneficial effects of IL‐22, whereas IGFBP5 supplementation restored endometrial receptivity and rescued implantation. Collectively, we showed that the suppression of the IL‐22‐STAT3‐IGFBP5 axis is a key contributor to impaired endometrial receptivity in PCOS, providing a potential therapeutic target for improving pregnancy outcomes via IGFBP5 supplementation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ovarian function and disorders · Reproductive System and Pregnancy · Cytokine Signaling Pathways and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education Beijing Key Laboratory of Collaborative Innovation in Frontier Technologies for Population Quality Beijing China

Reproductive Medicine Department The First Affiliated Hospital of Shihezi University Shihezi China

Center for Precision Medicine Multi‐Omics Research Institute of Advanced Clinical Medicine Peking University Beijing China

Beijing Advanced Center of Cellular Homeostasis and Aging‐Related Diseases Institute of Advanced Clinical Medicine Peking University Beijing China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (43)

Show source-provided references
1. 10.1016/S2213‐8587(22)00163‐210.1016/S2213‐8587(22)00163‐2 ↗
2. 10.1016/j.cmet.2024.01.00210.1016/j.cmet.2024.01.002 ↗
3. 10.1007/s43032‐021‐00629‐910.1007/s43032‐021‐00629‐9 ↗
4. 10.1093/humupd/dmaa05110.1093/humupd/dmaa051 ↗
5. 10.1126/sciadv.adu369910.1126/sciadv.adu3699 ↗
6. 10.1016/j.rbmo.2017.07.01010.1016/j.rbmo.2017.07.010 ↗
7. 10.1007/s00404‐020‐05699‐910.1007/s00404‐020‐05699‐9 ↗
8. 10.1093/humupd/dml03310.1093/humupd/dml033 ↗
9. 10.1016/j.devcel.2023.08.00410.1016/j.devcel.2023.08.004 ↗
10. 10.1242/jcs.17594310.1242/jcs.175943 ↗
11. 10.1038/s41591‐025‐03592‐z10.1038/s41591‐025‐03592‐z ↗
12. 10.1016/j.mce.2010.08.00610.1016/j.mce.2010.08.006 ↗
13. 10.1210/clinem/dgaf10010.1210/clinem/dgaf100 ↗
14. 10.1210/clinem/dgaa95110.1210/clinem/dgaa951 ↗
15. 10.3390/ijms2502120310.3390/ijms25021203 ↗
16. 10.1093/biolre/iox18210.1093/biolre/iox182 ↗
17. 10.3389/fimmu.2022.95557610.3389/fimmu.2022.955576 ↗
18. 10.1038/s41591‐019‐0509‐010.1038/s41591‐019‐0509‐0 ↗
19. 10.1038/ncb351610.1038/ncb3516 ↗
20. 10.1093/humrep/deae13710.1093/humrep/deae137 ↗
21. 10.1073/pnas.04002301010.1073/pnas.040023010 ↗
22. 10.1038/s41419‐020‐02844‐910.1038/s41419‐020‐02844‐9 ↗
23. 10.1530/REP‐14‐038610.1530/REP‐14‐0386 ↗
24. 10.1038/nm.277110.1038/nm.2771 ↗
25. 10.1093/molehr/gah14910.1093/molehr/gah149 ↗
26. 10.1093/biolre/ioab07710.1093/biolre/ioab077 ↗
27. 10.1210/endrev/bnaa01010.1210/endrev/bnaa010 ↗
28. 10.1016/j.theriogenology.2020.02.04410.1016/j.theriogenology.2020.02.044 ↗
29. 10.1095/biolreprod.104.03608710.1095/biolreprod.104.036087 ↗
30. 10.1161/HYPERTENSIONAHA.116.0848310.1161/HYPERTENSIONAHA.116.08483 ↗
31. 10.1158/1078‐0432.CCR‐06‐224510.1158/1078‐0432.CCR‐06‐2245 ↗
32. 10.1042/BJ2006008610.1042/BJ20060086 ↗
33. 10.1038/s41419‐022‐04803‐y10.1038/s41419‐022‐04803‐y ↗
34. 10.1038/s41467‐023‐37306‐110.1038/s41467‐023‐37306‐1 ↗
35. 10.1038/s43587‐025‐00859‐510.1038/s43587‐025‐00859‐5 ↗
36. 10.1096/fj.12‐22566410.1096/fj.12‐225664 ↗
37. 10.1210/clinem/dgz11710.1210/clinem/dgz117 ↗
38. 10.1210/en.2014‐156610.1210/en.2014‐1566 ↗
39. 10.1095/biolreprod67.4.126810.1095/biolreprod67.4.1268 ↗
40. 10.1530/JOE‐19‐058910.1530/JOE‐19‐0589 ↗
41. 10.1007/BF0282050710.1007/BF02820507 ↗
42. 10.1172/JCI1045910.1172/JCI10459 ↗
43. 10.1210/endo.140.12.717510.1210/endo.140.12.7175 ↗